We’re back with another TDR Psychedelic Exclusive. In this latest, we connect again with the CEO of Numinus Wellness (TSX: NUMI), Payton Nyquvest. In case
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of June 12. Aside from presenting a synopsis of events, we provide
The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study
Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the drugmaker’s pursuit of an immunology blockbuster. In a news release on
An Indian manufacturer will establish its first location outside the Indian subcontinent in New Jersey. Choose New Jersey, a nonprofit that works to bring businesses
Pharmacyclics is bringing its BTK battle to court. The AbbVie unit filed suit against BeiGene on Tuesday, alleging the company’s competing blood cancer drug Brukinsa
In a head-to-head clinical trial, Eli Lilly’s injectable migraine drug Emgality was not superior to the Nurtec ODT tablets out of Pfizer on a primary
The Republican-led House Appropriations Committee on Wednesday advanced the 2024 FDA spending bill by a 34-27 vote after Democrats failed to remove language in the bill
A bipartisan group of US senators has released a congressional call to the public for ideas and policy solutions on how to improve the 340B
Pharma advertising award submissions for the annual Cannes Lions creativity festival rose by almost 20% this year, signaling a return to business as usual after